Terms: = Colorectal cancer AND CgA AND Prognosis
18 results:
1. Geriatric factors associated with overall survival in older patients with metastatic colorectal cancer.
Dardaine V; Cancel M; Inyambo K; Biogeau J; Sauger C; Lecomte T; Dorval E
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102280. PubMed ID: 38182006
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
[No Abstract] [Full Text] [Related]
4. colorectal cancer in Elderly Patients with Surgical Indication: State of the Art, Current Management, Role of Frailty and Benefits of a Geriatric Liaison.
González-Senac NM; Mayordomo-Cava J; Macías-Valle A; Aldama-Marín P; Majuelos González S; Cruz Arnés ML; Jiménez-Gómez LM; Vidán-Astiz MT; Serra-Rexach JA
Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199923
[TBL] [Abstract] [Full Text] [Related]
5. Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters.
Giannotti C; Zoppoli G; Ferrando L; Murialdo R; Caffa I; Laudisio A; Scabini S; Romairone E; Fregatti P; Friedman D; Odetti P; Nencioni A; Ballestrero A; Monacelli F
J Geriatr Oncol; 2020 May; 11(4):610-616. PubMed ID: 31706829
[TBL] [Abstract] [Full Text] [Related]
6. Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: A case report.
Li T; Liu T; Wang M; Zhang M
Medicine (Baltimore); 2018 Sep; 97(37):e12359. PubMed ID: 30212993
[TBL] [Abstract] [Full Text] [Related]
7. [Risk Assessment of Chemotherapy for the Elderly Patients with Gastrointestinal cancer].
Hamaguchi T
Gan To Kagaku Ryoho; 2018 Jan; 45(1):12-15. PubMed ID: 29362298
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
Koenig A; Krug S; Mueller D; Barth PJ; Koenig U; Scharf M; Ellenrieder V; Michl P; Moll R; Homayunfar K; Kann PH; Stroebel P; Gress TM; Rinke A
PLoS One; 2017; 12(12):e0188876. PubMed ID: 29232390
[TBL] [Abstract] [Full Text] [Related]
9. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
[TBL] [Abstract] [Full Text] [Related]
10. Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients.
Brunello A; Fontana A; Zafferri V; Panza F; Fiduccia P; Basso U; Copetti M; Lonardi S; Roma A; Falci C; Monfardini S; Cella A; Pilotto A; Zagonel V
J Cancer Res Clin Oncol; 2016 May; 142(5):1069-77. PubMed ID: 26758276
[TBL] [Abstract] [Full Text] [Related]
11. Neuroendocrine differentiation is a prognostic factor for stage II poorly differentiated colorectal cancer.
Liu Y; Xu J; Jiao Y; Hu Y; Yi C; Li Q; Tong Z; Wang X; Hu L; Xiao Q; Li J; Ding K
Biomed Res Int; 2014; 2014():789575. PubMed ID: 25093184
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract] [Full Text] [Related]
13. Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma.
Yu DC; Bury JP; Tiernan J; Waby JS; Staton CA; Corfe BM
Mol Cancer; 2011 Mar; 10():27. PubMed ID: 21401950
[TBL] [Abstract] [Full Text] [Related]
14. Correlation between chromogranin-A expression and pathological variables in human colon carcinoma.
Indinnimeo M; Cicchini C; Memeo L; Stazi A; Provenza C; Ricci F; Mingazzini PL
Anticancer Res; 2002; 22(1A):395-8. PubMed ID: 12017321
[TBL] [Abstract] [Full Text] [Related]
15. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.
Wu JT; Erickson AJ; Tsao KC; Wu TL; Sun CF
Ann Clin Lab Sci; 2000 Apr; 30(2):175-8. PubMed ID: 10807161
[TBL] [Abstract] [Full Text] [Related]
16. [Significance of endocrine cells and their hormones in colorectal cancer].
Yin J; Liang Y; Wang H
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):192-5. PubMed ID: 10920894
[TBL] [Abstract] [Full Text] [Related]
17. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract] [Full Text] [Related]
18. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
[TBL] [Abstract] [Full Text] [Related]
